List of publications

List of publications Juvela 1

LIST OF PUBLICATIONS

Section A

A. Original articles in international peer-reviewed scientific journals

1. Juvela S, Kaste M, Hillbom M. The effects of earlier surgery and shorter bedrest on the outcome in

patients with subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1989; 52: 776-777. (IF=

5.580)

2. Palomäki H, Partinen M, Juvela S, Kaste M. Snoring as a risk factor for sleep-related brain infarction.

Stroke 1989; 20: 1311-1315. (IF= 6.018)

3. Juvela S, Heiskanen O, Poranen A, Valtonen S, Kuurne T, Kaste M, Troupp H. The treatment of

spontaneous intracerebral hemorrhage: a prospective randomized trial of surgical and conservative

treatment. J Neurosurg 1989; 70: 755-758. (IF= 3.227)

4. Juvela S. Rebleeding from ruptured intracranial aneurysms. Surg Neurol 1989; 32: 323-326. (IF= 2.417)

5. Juvela S, Kaste M, Hillbom M. Platelet thromboxane release after subarachnoid hemorrhage and surgery.

Stroke 1990; 21: 566-571. (IF= 6.018)

6. Juvela S, Kaste M, Hillbom M. Effect of nimodipine on platelet function in patients with subarachnoid

hemorrhage. Stroke 1990; 21: 1283-1288. (IF= 6.018)

7. Juvela S. Cerebral infarction and release of platelet thromboxane after subarachnoid hemorrhage.

Neurosurgery 1990; 27: 929-935. (IF= 3.031)

8. Juvela S, Kaste M. Reduced platelet aggregability and thromboxane release after rebleeding in patients

with subarachnoid hemorrhage. J Neurosurg 1991; 74: 21-26. (IF= 3.227)

9. Juvela S, Hillbom M, Kaste M. Platelet thromboxane release and delayed cerebral ischemia in patients

with subarachnoid hemorrhage. J Neurosurg 1991; 74: 386-392. (IF= 3.227)

10. Juvela S, Öhman J, Servo A, Heiskanen O, Kaste M. Angiographic vasospasm and release of platelet

thromboxane after subarachnoid hemorrhage. Stroke 1991; 22: 451-455. (IF= 6.018)

11. Juvela S. Minor leak before rupture of an intracranial aneurysm and subarachnoid hemorrhage of

unknown etiology. Neurosurgery 1992; 30: 7-11. (IF= 3.031)

12. Juvela S. Alcohol consumption as a risk factor for poor outcome after aneurysmal subarachnoid

haemorrhage. Brit Med J 1992; 304: 1663-1667. (IF= 14.093)

13. Haapaniemi H, Hillbom M, Numminen H, Juvela S, Palomäki H, Kaste M. Early-morning increase in

onset of ischemic stroke. Cerebrovasc Dis 1992; 2: 282-286. (IF= 3.698)

14. Juvela S, Hillbom M, Numminen H, Koskinen P. Cigarette smoking and alcohol consumption as risk

factors for aneurysmal subarachnoid hemorrhage. Stroke 1993; 24: 639-646. (IF= 6.018)

15. Juvela S, Porras M, Heiskanen O. Natural history of unruptured intracranial aneurysms: a long-term

follow-up study. J Neurosurg 1993; 79: 174-182. (IF= 3.227)

16. Palomäki H, Kaste M, Raininko R, Salonen O, Juvela S, Sarna S. Risk factors for cervical atherosclerosis

in patients with transient ischemic attack or minor ischemic stroke. Stroke 1993; 24: 970-975. (IF=

6.018)

17. Juvela S. Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J

Neurosurg 1995; 82: 945-952. (IF= 3.227)

18. Juvela S, Hillbom M, Palomäki H. Risk factors for spontaneous intracerebral hemorrhage. Stroke 1995;

26: 1558-1564. (IF= 6.018)

19. Juvela S. Risk factors for impaired outcome after spontaneous intracerebral hemorrhage. Arch Neurol

1995; 52: 1193-1200. (IF= 7.008)

20. Hillbom M, Haapaniemi H, Juvela S, Palomäki H, Numminen H, Kaste M. Recent alcohol consumption,

cigarette smoking, and cerebral infarction in young adults. Stroke 1995; 26: 40-45. (IF= 6.018)

21. Juvela S. Prevalence of risk factors in spontaneous intracerebral hemorrhage and aneurysmal


subarachnoid hemorrhage. Arch Neurol 1996; 53: 734-740. (IF= 7.008)

22. Haapaniemi H, Hillbom M, Juvela S. Weekend and holiday increase in the onset of ischemic stroke in

young women. Stroke 1996; 27: 1023-1027. (IF= 6.018)

23. Haapaniemi H, Salonen O, Hillbom M, Juvela S. Carotid arterial dissection as a cause of severe brain

infarction in young adults. J Stroke Cerebrovasc Dis 1996; 6: 89-92. (IF= 1.993)

24. Numminen H, Hillbom M, Juvela S. Platelets, alcohol consumption and onset of brain infarction. J

Neurol Neurosurg Psychiatry 1996; 61: 376-380. (IF= 5.580)

25. Haapaniemi H, Hillbom M, Juvela S. Lifestyle-associated risk factors for acute brain infarction among

persons of working age. Stroke 1997; 28: 26-30. (IF= 6.018)

26. Peltonen S, Juvela S, Kaste M, Lassila R. Hemostasis and fibrinolysis activation after subarachnoid

hemorrhage. J Neurosurg 1997; 87: 207-214. (IF= 3.227)

27. Hillbom M, Juvela S, Numminen H. Alcohol intake and the risk of stroke. J Cardiovasc Risk 1999; 6:

223-228. (IF= 2.634)

28. Hillbom M, Numminen H, Juvela S. Recent heavy drinking of alcohol and embolic stroke. Stroke 1999;

30: 2307-2312. (IF= 6.018)

29. Niemi T, Tanskanen P, Taxell C, Juvela S, Randell T, Rosenberg P. Effects of nonsteroidal anti-

inflammatory drugs on hemostasis in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg

Anesth 1999; 11: 188-194. (IF= 2.347)

30. Juvela S. Risk factors for multiple intracranial aneurysms. Stroke 2000; 31: 392-397. (IF= 6.018)

31. Juvela S. Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage. J Neurosurg

2000; 92: 390-400. (IF= 3.227)

32. Juvela S, Porras M, Poussa K. Natural history of unruptured intracranial aneurysms: probability and risk

factors for aneurysm rupture. Neurosurgical Focus 2000; 8: 1-9. (IF= 2.135)

33. Juvela S, Porras M, Poussa K. Natural history of unruptured intracranial aneurysms: probability of and

risk factors for aneurysm rupture. J Neurosurg 2000; 93: 379-387. (IF= 3.227)

34. Porras M, Juvela S. Spinal cord and spinal dural arteriovenous fistulas and intradural calcification. Klin

Neuroradiol 2000; 10: 161-165. (IF= -)

35. Juvela S, Poussa K, Porras M. Factors affecting formation and growth of intracranial aneurysms: a long-

term follow-up study. Stroke 2001; 32: 485-491. (IF= 6.018)

36. Saloheimo P, Juvela S, Hillbom M. Use of aspirin, epitaxis, and untreated hypertension as risk factors for

primary intracerebral hemorrhage in middle-aged and elderly people. Stroke 2001: 32: 399-404. (IF=

6.018)

37. Juvela S. Natural history of unruptured intracranial aneurysms: risks for aneurysm formation, growth, and

rupture. Acta Neurochir (suppl) 2002; 82: 27-30. (IF= 1.788)

38. Juvela S. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme

activity following aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 97: 1287-1293. (IF= 3.227)

39. Juvela S. Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke 2003; 34: 1852-

1857. (IF= 6.018)

40. Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, Hernesniemi J, Lassila R. No effect of

enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-

controlled clinical trial. J Neurosurg 2003; 99: 953-959. (IF= 3.227)

41. Vilkki JS, Juvela S, Siironen J, Ilvonen T, Varis J, Porras M. Relationship of local infarctions to

cognitive and psychosocial impairments after aneurysmal subarachnoid hemorrhage. Neurosurgery 2004;

55: 790-803. (IF= 3.031)

42. Juvela S, Siironen J, Varis J, Poussa K, Porras M. Risk factors for ischemic lesions following aneurysmal

subarachnoid hemorrhage. J Neurosurg 2005; 102: 194-201. (IF= 3.227)

43. Juvela S, Siironen J, Kuhmonen J. Hyperglycemia, excess weight, and history of hypertension as risk

factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg

2005; 102: 998-1003. (IF= 3.227)


44. Ilveskero S, Juvela S, Siironen J, Lassila R. D-dimer predicts outcome after aneurysmal subarachnoid

hemorrhage: no effect of thromboprophylaxis on coagulation activity. Neurosurgery 2005; 57: 16-24.

(IF= 3.031)

45. Saloheimo P, Juvela S, Riutta A, Pyhtinen J, Hillbom M. Thromboxane and prostacyclin biosynthesis in

patients with acute spontaneous intracerebral hemorrhage. Thromb Res 2005; 115: 367-373. (IF= 2.440)

46. Juvela S, Siironen J. D-dimer as an independent predictor for poor outcome after aneurysmal

subarachnoid hemorrhage. Stroke 2006; 37: 1451-1456. (IF= 6.018)

47. Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen E-R, Hillbom M. Regular aspirin-use

preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke

2006; 37: 129-133. (IF= 6.018)

48. Saloheimo P, Lapp T-M, Juvela S, Hillbom M. The impact of functional status at three months on long-

term survival after spontaneous intracerebral hemorrhage. Stroke 2006; 37: 487-491. (IF= 6.018)

49. Siironen J, Juvela S, Kanarek K, Vilkki J, Hernesniemi J, Lappalainen J. The Met allele of the BDNF

Val66Met polymorphism predicts poor outcome among survivors of aneurysmal subarachnoid

hemorrhage. Stroke 2007; 38: 2858-2860. (IF= 6.018)

50. Siironen J, Porras M, Varis J, Poussa K, Hernesniemi J, Juvela S. Early ischemic lesion on computed

tomography: predictor of poor outcome among survivors of aneurysmal subarachnoid hemorrhage. J

Neurosurg 2007; 107: 1074-1079. (IF= 3.227)


risk factors for aneurysm rupture (historical article). J Neurosurg 2008; 108: 1052-1060. (IF= 3.227)

52. Hernesniemi J, Dashti R, Juvela S, Väärt K, Niemelä M, LaaksoA. Natural history of brain arteriovenous

malformations: A long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery 2008,

63: 823-829. (IF= 3.031)

53. Laaksamo E, Tulamo R, Baumann M, Dashti R, Hernesniemi J, Juvela S, Niemelä M, Laakso A.

Involvement of mitogen-activated protein kinase signaling in growth and rupture of human intracranial

aneurysms. Stroke 2008; 39: 886-892. (IF= 6.018)

54. Laakso A, Dashti R, Seppänen J, Juvela S, Väärt K, Niemelä M, Sankila R, Hernesniemi H. Long-term

excess mortality in 623 patients with brain arteriovenous malformations. Neurosurgery 2008; 63: 244-

255. (IF= 3.031)

55. Lehecka M, Lehto H, Niemelä M, Juvela S, Dashti R, Koivisto T, Ronkainen A, Rinne J, Jääskeläinen

JE, Hernesniemi J. Distal anterior cerebral artery aneurysms: treatment and outcome analysis of 501

patients. Neurosurgery 2008; 62: 590-601. (IF= 3.031)

56. Tetri S, Mäntymäki L, Juvela S, Saloheimo P, Pyhtinen J, Rusanen H, Hillbom M.

Impact of ischemic heart disease and atrial fibrillation on survival after spontaneous intracerebral

hemorrhage. J Neurosurg 2008; 108: 1172-1177. (IF= 3.227)

57. Tetri, S, Hakala J, Juvela S, Saloheimo P, Pyhtinen J, Rusanen H, Savolainen E-R, Hillbom M. Safety of

low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary

intracerebral haemorrhage. Thromb Res 2008; 123: 206-212. (IF= 2.440)

58. Vilkki J, Lappalainen J, Juvela S, Kanarek K, Hernesniemi J, Siironen J. Relationship of the met allele of

the brain-derived neurotrophic factor val66met polymorphism to memory after aneurysmal subarachnoid

hemorrhage. Neurosurgery 2008; 63: 198-203. (IF= 3.031)

59. Juvela S, Siironen J, Lappalainen J. Apolipoprotein E genotype and outcome after aneurysmal

subarachnoid hemorrhage. J Neurosurg 2009; 110: 989-995, erratum 1042. (IF= 3.227)

60. Saloheimo P, Tetri S, Juvela S, Pyhtinen J, Hillbom M. Seasonal variation of intracerebral hemorrhage in

subjects with untreated hypertension. Acta Neurol Scand 2009; 120: 59-63. (IF= 2.437)

61. Tetri S, Juvela S, Saloheimo P, Pyhtinen J, Hillbom M. Hypertension and diabetes as predictors of early

death after spontaneous intracerebral hemorrhage. J Neurosurg 2009; 110: 411-417. (IF= 3.227)

62. Laakso A, Dashti R, Juvela S, Niemelä M, Hernesniemi J. Natural history of arteriovenous

malformations: presentation, risk of hemorrhage and mortality. Acta Neurochir (suppl) 2010; 107: 65-


69. (IF= 1.788)

63. Tetri S, Huhtakangas J, Juvela S, Saloheimo P, Pyhtinen J, Hillbom M. Better than expected survival

after primary intracerebral hemorrhage in patients with untreated hypertension despite high admission

blood pressures. Eur J Neurol 2010; 27: 708-714. (IF= 3.852)

64. Thompson BB, Béjot Y, Caso V, Castillo J, Christensen H, Flaherty ML, Foerch C, Ghandehari K,

Giroud M, Greenberg SM, Hallevi H, Hemphill III JC, Heuschmann P, Juvela S, Kimura K, Myint PK,

Nagakane Y, Naritomi H, Passero S, Rodríguez-Yáñez MR, Roquer J, Rosand J, Rost NS, Saloheimo P,

Salomaa V, Sivenius J, Sorimachi T, Togha M, Toyoda K, Turaj W, Vemmos KN, Wolfe CDA, Woo D,

Smith EE. Prior Antiplatelet Therapy and Outcome Following Intracerebral Hemorrhage: Systematic

Review and Meta-Analysis. Neurology 2010; 75: 1333-1342. (IF= 8.303)

65. Laakso A, Dashti R, Juvela S, Isarakul P, Niemelä M, Hernesniemi J. Risk of hemorrhage in patients with

untreated Spetzler-Martin grade IV and V arteriovenous malformations: a long-term follow-up study in 63

patients. Neurosurgery 2011; 68: 372-378. (IF= 3.031)

66. Huhtakangas J, Tetri S, Juvela S, Saloheimo P, Bode MK, Hillbom M. Effect of increased warfarin use

on warfarin-related cerebral hemorrhage: a longitudinal population-based study. Stroke 2011; 42: 2431-

2435. (IF= 6.018)

67. Posti J, Juvela S, Parkkola R, Roine S. Three cases of superficial siderosis of the central nervous system

and review of the literature. Acta Neurochir 2011; 153: 2067-2073. (IF= 1.788)

68. Juvela S, Siironen J. Early cerebral infarction as a risk factor for poor outcome after aneurysmal

subarachnoid haemorrhage. Eur J Neurol 2012; 19: 332-339. (IF= 3.852)

69. Juvela S, Kuhmonen J, Siironen J. C-reactive protein as predictor for poor outcome after aneurysmal

subarachnoid haemorrhage. Acta Neurochir 2012; 154: 397-404. (IF= 1.788)

70. Gregson BA, Broderick JP, Auer LM, Batjer H, Chen X-C, Juvela S, Morgenstern LB, Pantazis GC,

Teernstra OPM, Wang W-Z, Zuccarello M, Mendelow AD. Individual patient data subgroup meta-

analysis of surgery for spontaneous supratentorial intracerebral haemorrhage. Stroke 2012; 43: 1496-

1504. (IF= 6.018)

71. Malmivaara K, Juvela S, Hernesniemi J, Lappalainen J, Siironen J. Health-related quality of life and cost-

effectiveness of treatment in subarachnoid haemorrhage. Eur J Neurol 2012; 19: 1455-1461. (IF= 3.852)

72. Vilkki J, Juvela S, Malmivaara K, Siironen J, Hernesniemi J. Predictors of work status and quality of life

9-13 years after aneurysmal subarachnoid hemorrhage. Acta Neurochir 2012; 154: 1437-1446. (IF=

1.788)

73. Vaaramo K, Puljula J, Tetri S, Juvela S, Hillbom M. Mortality of harmful drinkers increased after

reduction of alcohol prices in northern Finland: a 10-year follow-up of head trauma subjects.

Neuroepidemiology 2012; 39: 156-162. (IF= 2.476)

74. Huhtakangas J, Löppönen P, Tetri S, Juvela S, Saloheimo P, Bode MK, Hillbom M. Predictors for

recurrent primary intracerebral hemorrhage: a retrospective population-based study. Stroke 2013; 44:

585-590. (IF= 6.018)

75. Löppönen P, Tetri S, Juvela S, Huhtakangas J, Saloheimo P, Bode MK, Koivukangas J, Hillbom M. A

population based study of outcomes after evacuation of primary supratentorial intracerebral hemorrhage.

Clin Neurol Neurosurg 2013; 115: 1350-1355. (IF= 1.248)

76. Puljula J, Lesonen S, Kortelainen M-L, Juvela S, Hillbom M. Mortality from traumatic brain injury after

reduction of alcohol prices: a population-based study from northern Finland. Scand J Public Health

2013; 41: 524-530. (IF= 3.012)

77. Juvela S, Poussa K, Lehto, H, Porras M. Natural history of unruptured intracranial aneurysms: a

long-term follow-up study. Stroke 2013; 44: 2414-2421. (IF= 6.018)

78. Vaaramo K, Puljula J, Tetri S, Juvela S, Hillbom M. Mortality of subjects with alcohol-related seizures

increased after alcohol cheapening. Acta Neurol Scand 2014; 129: 56-60. (IF= 2.437)

79. Greving JP, Wermer MJH, Brown RD Jr, Morita A, Juvela S, Yonekura M, Ishibashi T, Torner JC,

Nakayama T, Rinkel GJE, Algra A. Development of the PHASES score for prediction of risk of rupture


of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol 2014; 13:

59-66. (IF= 21.823)

80. Hillbom M, Saloheimo P, Fujioka S, Wszolek ZK, Juvela S, Leone MA. Diagnosis and management of

Marchiafava-Bignami disease: a review of CT/MRI confirmed cases. J Neurol Neurosurg Psychiatry

2014; 85: 168-173. (IF= 5.580)

81. Vaaramo K, Puljula J, Tetri S, Juvela S, Hillbom M. Head trauma sustained under the influence of

alcohol is a predictor for future traumatic brain injury: a long-term follow-up study. Eur J Neurol 2014;

21: 293-298. (IF= 3.852)

82. Löppönen P, Tetri S, Juvela S, Huhtakangas J, Saloheimo P, Bode MK, Hillbom M. Association between

warfarin combined with serotonin-modulating antidepressants are and increased case fatality in primary

intracerebral hemorrhage: a population-based study. J Neurosurg 2014; 120: 1358-1363. (IF= 3.227)

83. Huhtakangas J, Tetri S, Juvela S, Saloheimo P, Bode MK, Karttunen V, Käräjämäki A, Hillbom M.

Improved survival of patients with warfarin associated intracerebral hemorrhage: a retrospective

longitudinal population-based study. Int J Stroke 2012; in press. (IF= 4.029)

84. Vaaramo K, Puljula J, Tetri S, Juvela S, Hillbom M. Predictors of new-onset seizures: a 10-year follow-

up of head trauma subjects with and without traumatic brain injury. J Neurol Neurosurg Psychiatry

2014; 85: 598-602. (IF= 5.580)

85. Etminan N, Beseoglu K, Barrow DL, Bederson J, Brown RD Jr., Connolly ES Jr., Derdeyn CP, Hänggi D,

Hasan D, Juvela S, Kasuya H, Kirkpatrick PJ, Knuckey N, Koivisto T, Lanzino G, Lawton MT, LeRoux

P, McDougall C, Mee E, Mocco J, Molyneux A, Morgan MK, Mori K, Morita A, Murayama Y, Nagahiro

S, Pasqualin A, Raabe A, Raymond J, Rinkel GJE, Rüfenacht D, Seifert V, Spears J, Steiger HJ,

Steinmetz H, Torner JC, Vajkoczy P, Wanke I, Wong GKC, Wong JH, Macdonald RL. Consensus on

assessment of unruptured intracranial aneurysms - proposal of an international research group. Stroke

2014; 45: 1523-1530. (IF= 6.018)

86. Qian C, Löppönen P, Tetri S, Huhtakangas J, Juvela S, Turtiainen H-ME, Bode MK, Hillbom M.

Immediate, early and late Seizures after primary intracerebral hemorrhage Epilepsy Res 2014; 108: 732-

739. (IF= 2.190)

87. Löppönen P, Qian C, Tetri S, Juvela S, Huhtakangas J, Bode MK, Hillbom M. Predictive value of C-

reactive protein for the outcome after primary intracerebral hemorrhage. J Neurosurg 2014; 121: 1374-

1379. (IF= 3.227)

88. Korja M, Lehto H, Juvela S. Lifelong rupture risk of intracranial aneurysms depends on risk factors: a

prospective Finnish cohort study. Stroke 2014; 45: 1958-1963. (IF= 6.018)

89. Juvela S, Lehto H. Risk factors for all-cause death after diagnosis of unruptured intracranial aneurysms.

Neurology 2015; 84: 456-463. (IF= 8.303)

90. Vaaramo K, Puljula J, Tetri S, Juvela S, Hillbom M. Head trauma with or without mild brain injury

increases the risk of future traumatic death: a controlled prospective 15-year follow-up study. J

Neurotrauma 62015 Jan 13. [Epub ahead of print]. (IF= 3.968)

91. Etminan N, Brown RD, Beseoglu K, Juvela S, Raymond J, Morita A, Torner JC, Derdeyn CP, Raabe A,

Mocco J, Korja M, Abdulazim A, Amin-Hanjani S, Al-Shahi Salman R, Barrow DL, Bederson J, Bonafe

A, Dumont AS, Fiorella DJ, Gruber A, Hankey GJ, Hasan DM, Hoh BL, Jabbour P, Kasuya H, Kelly ME,

Kirkpatrick PJ, Knuckey N, Koivisto T, Krings T, Lawton MT, Marotta TR, Mayer SA, Mee E, Pereira

VM, Molyneux A, Morgan MK, Mori K, Murayama Y, Nagahiro S, Nakayama N, Niemelä M, Ogilvy

CS, Pierot L, Rabinstein AA, Roos YBWEM, Rinne J, Rosenwasser RH, Ronkainen A, Schaller K,

Seifert V, Solomon RA, Spears J, Steiger H-J, Vergouwen MDI, Wanke I, Wermer MJH, Wong GKC,

Wong JH, Zipfel GJ, Connolly ES Jr, Steinmetz H, Lanzino G, Pasqualin A, Rüfenacht D, Vajkoczy P,

McDougall C, Hänggi D, LeRoux P, Rinkel GJE, Macdonald RL. The Unruptured Intracranial Aneurysm

Treatment Score: a multidisciplinary consensus. Neurology 2015; (in press) (IF= 8.303)

92. Puljula J, Vaaramo K, Tetri S, Juvela S, Hillbom M. Risk for all-cause and traumatic death in head

trauma subjects: a prospective population-based case-control follow-up study. Ann Surg 2015; (in press)

(rank 1/204 – Q1 Surgery; IF= 7.188)


B. Original articles in international textbooks

93. Palomäki H, Partinen M, Juvela S, Kaste M. Snoring and occurrence of brain infarction, in Chouard CH

(ed): Chronic rhonchopathy. Kent, John Libbey Eurotext Ltd., 1988, pp 105-108.

C. Case reports

94. Laiho K, Belt EA, Juvela S, Paetau A, Soini I. Thigh pain due to intraspinal neurilemmoma [Clinical

picture]. Lancet 2003; 362: 533. (IF= 38.278)

None

D. Reviews, editorials and editorial comments in international peer-reviewed scientific journals or

textbooks

95. Juvela S, Heiskanen O, Poranen A, Valtonen S, Kuurne T, Kaste M, Troupp H. Surgical vs. conservative

treatment for spontaneous ICH [Letter]. J Neurosurg 1990; 72: 154-155. (IF= 3.227)

96. Juvela S, Porras M, Heiskanen O. Natural history of unruptured aneurysms [Letter]. J Neurosurg 1994;

80: 773-774. (IF= 3.227)

97. Hillbom M, Juvela S. Alcohol and risk for stroke, in Zakhari S, Wassef M (eds): Alcohol and the

cardiovascular system. National Institute on Alcohol Abuse and Alcoholism, NIH Pub. No 96-4133.

Washington DC, U.S. Government Printing Office, 1996, pp 63-83.

98. Juvela S. Smoking and vasospasm [Letter]. J Neurosurg 1998; 88: 788-789. (IF= 3.227)

99. Hillbom M, Juvela S, Karttunen V. Mechanisms of alcohol-related strokes, in Chadwick DJ, Goode JA

(eds): Alcohol and Cardiovascular Diseases. Novartis Foundation Symposium 216. John Wiley & Sons,

Chichester. pp 193-207, 1998.

100. Juvela S. Alcohol abuse and hemorrhagic stroke, in Watson RR, Myers AK (eds): Alcohol and heart

disease. Taylor & Francis, London, 2002, 58-71.

101. Juvela S. Recommendations for the management of patients with unruptured intracranial aneurysms

[Letter]. Stroke 2001; 32: 815-816. (IF= 6.018)

102. Juvela S. Cigarette smoking and death following subarachnoid hemorrhage [Editorial]. J Neurosurg

2001; 95: 551-554. (IF= 3.227)

103. Juvela S, Hernesniemi J. Efficacy of intrathecal liposomal fasudil for experimental cerebral vasospasm

after subarachnoid hemorrhage [Editorial comment]. Neurosurgery 2001; 48: 900. (IF= 3.031)

104. Juvela S, Hernesniemi J. Inhibition of endothelin-converting enzyme activity in the rabbit basilar artery

[Editorial comment]. Neurosurgery 2001; 48: 908. (IF= 3.031)

105. Juvela S. Risk of subarachnoid hemorrhage from a de novo aneurysm [Letter]. Stroke 2001; 32:1933-

1934. (IF= 6.018)

106. Juvela S, Hernesniemi J. Clinical manifestations and survival rates among patients with saccular

intracranial aneurysms: population-based study in Olmsted County, Minnesota, 1965 to 1995 [Letter].

Neurosurgery 2002; 50: 1167-1168. (IF= 3.031)

107. Juvela S. Unruptured aneurysms [Editorial]. J Neurosurg 2002; 96: 58-60. (IF= 3.227)

108. Juvela S. Hypertension and aneurysmal subarachnoid hemorrhage [Editorial]. Wien Klin Wochenschr

2002; 114: 285-286. (IF= 0.809)

109. Juvela S. Risk factors for aneurysmal subarachnoid hemorrhage [Letter]. Stroke 2002;33:2152. (IF=

6.018)

110. Juvela S. Growth of small unruptured intracranial aneurysm [Editorial comment]. Surg Neurol 2002; 58:


156-157. (IF= 2.417)

111. Juvela S. Nonsteroidal anti-inflammatory drugs as risk factors for spontaneous intracerebral hemorrhage

and aneurysmal subarachnoid hemorrhage [Letter]. Stroke 2003; 34:e34-e36. (IF= 6.018)

112. Juvela S, Hernesniemi J. Size of cerebral aneurysms and related factors in patients with subarachnoid

hemorrhage [Comment]. Surg Neurol 2004; 61: 246-247. (IF= 2.417)

113. Juvela S, Hernesniemi J. Is aspect ration a reliable predictor of intracranial aneurysm rupture? [Editorial

comment]. Neurosurgery 2004; 54: 1347. (IF= 3.031)

114. Juvela s. Treatment options of unruptured intracranial aneurysms. Stroke 2004; 35: 372-374. (IF= 6.018)

115. Juvela S. Recurrent primary intracerebral hemorrhage in Izumo City, Japan [Comment]. Surg Neurol

2005; 64: 28-36. (IF= 2.417)

116. Juvela S. Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage [Editorial]. J

Neurosurg 2005; 102: 975-976. (IF= 3.227)

117. Juvela S, Kase CS. Advances in intracerebral hemorrhage management. Stroke 2006; 37: 301-304. (IF=

6.018)

118. Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I, Juvela S, Marchel A, Chapot R,

Cognard C, Unterberg A, Hacke W. Recommendations for the management of intracerebral haemorrhage

- part I: spontaneous intracerebral haemorrhage. The European stroke initiative writing committee and the

writing committee for the EUSI executive committee. Cerebrovasc Dis 2006; 22: 294-316. (IF= 3.698)

119. Juvela S. Prognosis after intracerebral hemorrhage [Editorial]. J Neurosurg 2008; 108; 1171. (IF=

3.227)

120. Juvela S, Siironen J. Cerebral ischemia after aneurysmal subarachnoid hemorrhage [letter]. Stroke 2009;

40: e 547. (IF= 6.018)

121. Vergouwen MDI, Vermeulen M, Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela

S, Yonas H, Terbrugge KG, Macdonald RL, Diringer MN, Broderick JP, Dreier JP, Roos EBWEM.

Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event

in clinical trials and observational studies – Proposal of a multidisciplinary research group. Stroke 2010;

41: 2391-2395. (IF= 6.018)

122. Saloheimo P, Tetri S, Juvela S, Hillbom M. Response to the letter of Dr Turin and colleagues. Acta

Neurol Scand 2010:121; 70. (IF= 2.437)


Cognard C, Unterberg A, Hacke W. Recommendations for the diagnosis and management of spontaneous

intracerebral haemorrhage, in Gilhus NE, Barnes M P, Brainin M (eds): European Handbook of

Neurological Management, Volume 2, Second Edition. Wiley-Blackwell, Oxford, UK, 2011, 253-277,

doi: 10.1002/9781444346268.ch18.

124. Hillbom M, Saloheimo P, Juvela S. Blood pressure, alcohol consumption, and the risk of stroke. Curr

Hypertens Rep 2011; 13: 208-213. (IF= 3.902)

125. Juvela S. Prevalence of and risk factors for intracranial aneurysms. Lancet Neurol 2011; 10: 595-597.

(IF= 21.823)

126. Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G. European Stroke Organisation

guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc

Dis 2013; 35: 93–112. (IF= 3.698)

127. Juvela S. C-reactive protein after aneurysmal subarachnoid haemorrhage [letter]. Acta Neurochir 2012;

154: 1013-1014. (IF= 1.788)

128. Korja M, Juvela S, Hernesniemi J. Unruptured cerebral aneurysms in a Japanese cohort [letter]. N Engl J

Med 2012; 367: 1268. (IF= 53.298)

129. Korja M, Lehto H, Juvela S. Response to letter regarding article, "Lifelong rupture risk of intracranial

aneurysms depends on risk factors: a prospective Finnish cohort study" [letter]. Stroke 2014; 45: e211

E. Original articles or reviews in domestic peer-reviewed journals or textbooks


130. Juvela S, Kuurne T. Aivoverenvuodon leikkaushoito. Duodecim 1989; 105: 705-709.

131. Juvela S. Platelet aggregation and thromboxane release in primary subarachnoid hemorrhage. University

of Helsinki. Helsinki, Yliopistopaino, 1991.

[dissertation].

132. Seppälä M, Juvela S. Aivovammojen syyt pääkaupunkiseudulla. Suom Lääkäril 1991; 46: 1987-1991.

133. Juvela S. Alkoholi ja lukinkalvonalaisen verenvuodon ennuste (pääkirjoitus). Duodecim 1993; 109: 355-

357.

134. Seppälä M, Juvela S. Aivovaltimospasmi subaraknoidaalivuodon komplikaationa. Tehohoito 1994; 12:

110-111.

135. Juvela S. Aivoverenkierron häiriöiden neurokirurginen hoito (pääkirjoitus). Duodecim 1995; 111: 1985-

1990.

136. Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen E-R, Hillbom M. Sairastumista edeltänyt

asetyylisalisyylihappolääkitys lisää aivoverenvuotopotilaiden kuolleisuutta. Duodecim 2006; 122, 261-

262.

137. Coco K, Turunen H, Sillanpää K, Juvela S. Nuorten monivammapotilaiden omaisten tiedollinen

tukeminen – kysely yliopistosairaaloiden hoitotyöntekijöille. Hoitotiede 2007; 19 (4); 202-211.

138. Juvela S. Neurokirurgian mahdollisuudet aivoverenvuodoissa. AVH – Aivoverenkiertohäiriöiden

erikoislehti 2/2011, s. 12-14.

139. Roine RO, Juvela S. Aivoverenvuoto. Kirjassa: Jousimaa JP, Alenius H, Atula S, Kattainen A, Kunnamo

I, Teikari M, toim. Lääkärin käsikirja, s. 1210-1211. Helsinki: Kustannus Oy Duodecim, 2011.

140. Roine RO, Juvela S. Lukinkalvonalaisen verenvuodon eli subaraknoidaalivuodon diagnostiikka. Kirjassa:

Mäkijärvi M, Harjola V-P, Päivä H, Valli J, Vaula E, toim. Akuuttihoito-opas, s. 389-391. Helsinki:

Kustannus Oy Duodecim, 2011.

141. Roine RO, Juvela S. Lukinkalvonalaisen verenvuodon hoito. Kirjassa: Mäkijärvi M, Harjola V-P, Päivä

H, Valli J, Vaula E, toim. Akuuttihoito-opas, s. 391-393. Helsinki: Kustannus Oy Duodecim, 2011.

142. Juvela S. Uutta toivoa aivoverenvuodon hoitoon? AVH – Aivoverenkiertohäiriöiden erikoislehti 4/2013,

s. 18.

143. Juvela S. Voidaanko aivoverenvuodon riskiä vähentää? Riskiarviointi on kustannustehokasta

terveydenhuoltoa. Duodecim 2014; 130: 2030-2032.

144. Juvela S. Voiko aivovaltimopullistuman vuotoriskiä arvioida yksilöllisesti? Kasvava

sattumalöydösongelma. Duodecim 2014; 130: 2138-2139.

145. Kaste M, Hernesniemi J, Juvela S, Lindsberg PJ, Palomäki H, Rissanen A, Roine RO, Sivenius J,

Vikatmaa P. Aivoverenkiertohäiriöt. Kirjassa: Kaste M, Soinila S, toim. Neurologia (painossa). Helsinki:

Kustannus Oy Duodecim, 2015.

Abstracts

A total of 86 abstracts have been published in journals or conference publications.


IF= impact factor of the journal (SCI Journal Citation Reports 2013)

An average impact factor score of journals of published original and review articles: 4.75 (469,929 points/

99 articles).

Distribution of published original and review articles in international peer-reviewed scientific

journals by impact factor of journal:

Cerebrovascular journals

Stroke: 29 * 6.018= 174.522

Int J Stroke: 1* 4.029= 4.029

Cerebrovasc Dis: 3 * 3.698= 11.094

J Stroke Cerebrovasc Dis: 1 * 1.993= 1.993

Neurosurgical journals

J Neurosurg: 19 * 3.227= 61.313

Neurosurgical Focus: 1 * 2.135= 2.135

Neurosurgery: 9 * 3.031= 27.279

Surg Neurol: 1 * 2.417= 2.417

Acta Neurochir: 5 * 1.788= 8.94

Neurological/neurosurgical journals

Lancet Neurol 2* 21.823= 43.646

Neurology: 3 * 8.303= 24.909

Arch Neurol: 2 * 7.008= 14.016

J Neurol Neurosurg Psychiatry: 4 * 5.580= 22.32

Eur J Neurol: 4 * 3.852= 15.408

Acta Neurol Scand: 2 * 2.437= 4.874

Neuroepidemiology: 1* 2.476= 2.476

Clin neurol neurosurg: 1* 1.248= 1.248

J Neurotrauma: 1* 3.968= 3.968

Epilepsy Res: 1* 2.190= 2.190

General medicine journal

Brit Med J: 1 * 17.215= 17.215

Surgical journal

Ann Surg: 1* 7.188= 7.188

Other journals

Thromb Res: 2 * 2.427= 4.854

Curr hypertens Rep: 1* 3.902= 3.902

J Neurosurg Anest: 1 * 2.347= 2.347

J Cardiovasc Risk: 1 * 2.634= 2.634

Scand J Public Health: 1* 3.012= 3.012

Klin Neuroradiol: 1 * 0= 0


Section B

May 21, 2015

H. h- index (WOS core collection): 36

h- index (WOS all data bases): 37

I. Sum of Times Cited without self-citations (WOS core collection): 3808

Average citations per item (WOS core collection): 40.87

Search included articles, letters, and reviews.

Section C

1. Juvela S, Heiskanen O, Poranen A, Valtonen S, Kuurne T, Kaste M, Troupp H. The treatment of

spontaneous intracerebral hemorrhage: a prospective randomized trial of surgical and conservative

treatment. J Neurosurg 1989; 70: 755-758. (IF= 3.227; rank 72/199 – Q2 Surgery; Cited 244; May 21,

2015)

2. Juvela S, Hillbom M, Numminen H, Koskinen P. Cigarette smoking and alcohol consumption as risk

factors for aneurysmal subarachnoid hemorrhage. Stroke 1993; 24: 639-646. (IF= 6.018; rank 11/194 –

Q1 Clinical Neurology; Cited 196; May 21, 2015)

3. Juvela S, Porras M, Heiskanen O. Natural history of unruptured intracranial aneurysms: a long-term

follow-up study. J Neurosurg 1993; 79: 174-182. (IF= 3.227; rank 21/204 – Q1 Surgery; Cited 330; May

21, 2015)

4. Juvela S, Hillbom M, Palomäki H. Risk factors for spontaneous intracerebral hemorrhage. Stroke 1995;

26: 1558-1564. (IF= 6.018; rank 11/194 – Q1 Clinical Neurology; Cited 107; May 21, 2015)

5. Juvela S. Risk factors for impaired outcome after spontaneous intracerebral hemorrhage. Arch Neurol

1995; 52: 1193-1200. (IF= 7.008; rank 10/194 – Q1 Clinical Neurology; Cited 130; May 21, 2015)


risk factors for aneurysm rupture. J Neurosurg 2000; 93: 379-387. (IF= 3.227; rank 21/204 – Q1 Surgery;

Cited 278; May 21, 2015)

7. Juvela S, Poussa K, Porras M. Factors affecting formation and growth of intracranial aneurysms: a long-

term follow-up study. Stroke 2001; 32: 485-491. (IF= 6.018; rank 11/194 – Q1 Clinical Neurology; Cited

217; May 21, 2015)

8. Juvela S. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme

activity following aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 97: 1287-1293. (IF= 3.227;

rank 21/204 – Q1 Surgery; Cited 37; May 21, 2015)

9. Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, Hernesniemi J, Lassila R. No effect of


enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-

controlled clinical trial. J Neurosurg 2003; 99: 953-959. (IF= 3.227; rank 21/204 – Q1 Surgery; Cited 61;

May 21, 2015)

10. Juvela S, Siironen J, Kuhmonen J. Hyperglycemia, excess weight, and history of hypertension as risk

factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg

2005; 102: 998-1003. (IF= 3.227; rank 21/204 – Q1 Surgery; Cited 66; May 21, 2015)


Cognard C, Unterberg A, Hacke W. Recommendations for the management of intracerebral haemorrhage

- part I: spontaneous intracerebral haemorrhage. The European stroke initiative writing committee and the

writing committee for the EUSI executive committee. Cerebrovasc Dis 2006; 22: 294-316. (IF= 3.698;

rank 41/194 – Q1 Clinical Neurology; Cited 191; May 21, 2015)

12. Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen E-R, Hillbom M. Regular aspirin-use

preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke

2006; 37: 129-133. (IF= 6.018; rank 11/194 – Q1 Clinical Neurology; Cited 91; May 21, 2015)

13. Hernesniemi J, Dashti R, Juvela S, Väärt K, Niemelä M, LaaksoA. Natural history of brain arteriovenous

malformations: A long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery 2008,

63: 823-829. (IF= 3.031; rank 28/204 – Q1 Surgery; Cited 160; May 21, 2015)

14. Vergouwen MDI, Vermeulen M, Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela

S, Yonas H, Terbrugge KG, Macdonald RL, Diringer MN, Broderick JP, Dreier JP, Roos EBWEM.

Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event

in clinical trials and observational studies – Proposal of a multidisciplinary research group. Stroke 2010;

41: 2391-2395. (IF= 6.018; rank 11/194 – Q1 Clinical Neurology; highly cited paper; Cited 153; May 21,

2015)

15. Gregson BA, Broderick JP, Auer LM, Batjer H, Chen X-C, Juvela S, Morgenstern LB, Pantazis GC,

Teernstra OPM, Wang W-Z, Zuccarello M, Mendelow AD. Individual patient data subgroup meta-

analysis of surgery for spontaneous supratentorial intracerebral haemorrhage. Stroke 2012; 43: 1496-

1504. (IF= 6.018; rank 11/194 – Q1 Clinical Neurology; Cited 36; May 21, 2015)

16. Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G. European Stroke Organisation

guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc

Dis 2013; 35: 93–112. (IF= 3.698; rank 41/194 – Q1 Clinical Neurology; highly cited paper; Cited 45;

May 21, 2015)

17. Juvela S, Poussa K, Lehto, H, Porras M. Natural history of unruptured intracranial aneurysms: a

long-term follow-up study. Stroke 2013; 44: 2414-2421. (IF= 6.018; rank 11/194 – Q1 Clinical

Neurology; Cited 23; May 21, 2015)

18. Greving JP, Wermer MJH, Brown RD Jr, Morita A, Juvela S, Yonekura M, Ishibashi T, Torner JC,

Nakayama T, Rinkel GJE, Algra A. Development of the PHASES score for prediction of risk of rupture

of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol 2014; 13:

59-66. (IF= 21.823; rank 1/194 – Q1 Clinical Neurology; highly cited paper; Cited 21; May 21, 2015)

19. Juvela S, Lehto H. Risk factors for all-cause death after diagnosis of unruptured intracranial aneurysms.

Neurology 2015; 84: 456-463. (IF= 8.303; rank 8/194 – Q1 Clinical Neurology; Cited 1 – published 3


months ago; May 21, 2015)

20. Etminan N, Brown RD, Beseoglu K, Juvela S, Raymond J, Morita A, Torner JC, Derdeyn CP, Raabe A,

Mocco J, Korja M, Abdulazim A, Amin-Hanjani S, Al-Shahi Salman R, Barrow DL, Bederson J, Bonafe

A, Dumont AS, Fiorella DJ, Gruber A, Hankey GJ, Hasan DM, Hoh BL, Jabbour P, Kasuya H, Kelly ME,

Kirkpatrick PJ, Knuckey N, Koivisto T, Krings T, Lawton MT, Marotta TR, Mayer SA, Mee E, Pereira

VM, Molyneux A, Morgan MK, Mori K, Murayama Y, Nagahiro S, Nakayama N, Niemelä M, Ogilvy

CS, Pierot L, Rabinstein AA, Roos YBWEM, Rinne J, Rosenwasser RH, Ronkainen A, Schaller K,

Seifert V, Solomon RA, Spears J, Steiger H-J, Vergouwen MDI, Wanke I, Wermer MJH, Wong GKC,

Wong JH, Zipfel GJ, Connolly ES Jr, Steinmetz H, Lanzino G, Pasqualin A, Rüfenacht D, Vajkoczy P,

McDougall C, Hänggi D, LeRoux P, Rinkel GJE, Macdonald RL. The Unruptured Intracranial Aneurysm

Treatment Score: a multidisciplinary consensus. Neurology 2015; (in press) (IF= 8.303; rank 8/194 – Q1

Clinical Neurology; May 21, 2015)

List of publications

Documents

Transcript of List of publications